NCT06286358 Aortopathy Relationship To Imagery and Kinocardiography Features (ARTIK)
| NCT ID | NCT06286358 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Université Libre de Bruxelles |
| Condition | Aortic Valve Disease |
| Study Type | OBSERVATIONAL |
| Enrollment | 180 participants |
| Start Date | 2024-03-07 |
| Primary Completion | 2026-10-05 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 180 participants in total. It began in 2024-03-07 with a primary completion date of 2026-10-05.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Kinocardiography (KCG) is a portable measurement technique developed to estimate cardiac mechanical performance by studying the vibrations produced by myocardial contraction during each heartbeat and transmitted to the body surface. The goal of this observational study is to learn about kinocardiography in patients with aortic valve disease (AVD) or thoracic aortic aneurysm (TAA). The investigators believe that this technology will enable to diagnose aortic valve disease and aortic aneurysm. In patients with AVD of different severities or TAA, the investigators will collect informations from echocardiography and/or cardiac magnetic resonance imaging, KCG recordings, phonocardiography (PCG) recordings, and video recordings. Researchers will also compare subjects without any AVD nor TAA to better understand these effects on KCG, PCG and video signal.
Eligibility Criteria
Inclusion Criteria * "Interventional treatment" group * Adults (\>18 y) * Interventional treatment indication for severe AVD and/or severe TAA, as decided by the Heart Team * "Aortic valve disease of different severities" group * Adults (\>18y) * Aortic stenosis and/or aortic regurgitation and/or bicuspidy of different severities confirmed by echocardiography and/or cardiac MRI * "Control" group : - Adults (\>18 y) appariated with the participants of other groups according to their age, sex, body surface area and LVEF Exclusion Criteria: * Any severe rhythm disorder such as frequent ventricular extrasystoles, atrial tachyarrhythmias * Subject's disabilty to give consent * Subjects suffering from aortic valve disease or thoracic aortic aneurysm will be excluded from the "control" group.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06286358 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Aortic Valve Disease. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06286358 currently recruiting?
Yes, NCT06286358 is actively recruiting participants. Contact the research team at elza.abdessater@ulb.be for enrollment information.
Where is the NCT06286358 trial being conducted?
This trial is being conducted at Brussels, Belgium.
Who is sponsoring the NCT06286358 clinical trial?
NCT06286358 is sponsored by Université Libre de Bruxelles. The trial plans to enroll 180 participants.